Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kate Krause, M.D.

Concepts (87)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Adenoma, Liver Cell22020321.420 Why?
Focal Nodular Hyperplasia12020290.710 Why?
Pneumonectomy1202211110.510 Why?
Liver Neoplasms2202043130.470 Why?
Carcinoma, Hepatocellular1202022920.290 Why?
Mastectomy, Segmental320229720.250 Why?
Radiotherapy, Adjuvant4202017910.250 Why?
Neoplasm, Residual2202410070.250 Why?
Lung Neoplasms22024132450.160 Why?
Lymphatic Irradiation120181150.150 Why?
Neoadjuvant Therapy3201928210.150 Why?
Tumor Burden1202418930.150 Why?
Skin Neoplasms3202257970.150 Why?
Radiation Pneumonitis120181020.150 Why?
Organs at Risk120183580.140 Why?
Neoplasm Recurrence, Local5202092730.130 Why?
DNA Copy Number Variations1202420120.130 Why?
Carcinoma, Lobular220154890.120 Why?
Antigens, Neoplasm1202219970.110 Why?
Soft Tissue Neoplasms1202211520.110 Why?
Melanoma2202256910.100 Why?
Watchful Waiting120175090.100 Why?
Breast Neoplasms52019210170.100 Why?
Radiotherapy, Intensity-Modulated120188010.100 Why?
Sarcoma1202217850.100 Why?
Carcinoma, Ductal, Breast2201510960.090 Why?
Receptor, erbB-23201525530.090 Why?
Mastectomy2201518320.090 Why?
Radiotherapy Planning, Computer-Assisted1201816590.090 Why?
CD4-Positive T-Lymphocytes1202243530.080 Why?
Mammaplasty1201912390.080 Why?
Rectal Neoplasms1201711520.080 Why?
Sex Factors12020105050.070 Why?
Neoplasm Staging42022111520.060 Why?
Lymph Node Excision2202013030.050 Why?
Receptors, Progesterone2201511300.040 Why?
Humans1320247583810.040 Why?
Lung1201899850.040 Why?
Adenocarcinoma1201763130.040 Why?
Lymph Nodes2202234850.040 Why?
Tomography, X-Ray Computed12022205000.040 Why?
Antigen-Presenting Cells120229640.040 Why?
Sentinel Lymph Node Biopsy120227330.040 Why?
Multicenter Studies as Topic1202217050.040 Why?
Extremities120228650.040 Why?
Neoplasm Invasiveness2201536170.040 Why?
Receptors, Estrogen2201522110.040 Why?
Thoracic Wall120181990.030 Why?
HLA Antigens1202213680.030 Why?
Prognosis42019295580.030 Why?
Follow-Up Studies42018390600.030 Why?
Tumor Cells, Cultured1202261270.030 Why?
Antineoplastic Combined Chemotherapy Protocols12015117090.030 Why?
Respiratory Function Tests1201816800.030 Why?
Probability1201824670.030 Why?
Magnetic Resonance Imaging12020362850.030 Why?
Immunoenzyme Techniques1201517050.030 Why?
Radiotherapy Dosage1201828960.020 Why?
Antineoplastic Agents12015135910.020 Why?
Survival Rate22015127210.020 Why?
Salvage Therapy1201712680.020 Why?
Tumor Microenvironment1202238400.020 Why?
Feasibility Studies1201851990.020 Why?
Lymphatic Metastasis1201529430.020 Why?
Patient Satisfaction1201934460.020 Why?
Disease Management1201725000.020 Why?
Chemotherapy, Adjuvant1201535270.020 Why?
Aged, 80 and over32015586810.020 Why?
Heart1201843820.020 Why?
Pilot Projects1201885540.020 Why?
Polymorphism, Single Nucleotide12024157730.010 Why?
Colorectal Neoplasms1202468520.010 Why?
Disease-Free Survival1201568210.010 Why?
Phenotype12022165340.010 Why?
Aged420181682170.010 Why?
Clinical Trials as Topic1201979850.010 Why?
Combined Modality Therapy1201585300.010 Why?
Male120203587420.010 Why?
Middle Aged420182195600.010 Why?
Adult420182199160.010 Why?
Female520193903160.010 Why?
Incidence12018212730.010 Why?
Young Adult22015588080.010 Why?
Time Factors12018398730.010 Why?
Neoplasms12024220300.010 Why?
Prospective Studies12015541360.010 Why?
Retrospective Studies12015801700.000 Why?
Krause's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.